account_id none on file
legal_name UroGen Pharma Ltd.
ticker URGN
cik 1668243
domain urogen.com
linkedin_company_url https://www.linkedin.com/company/urogenpharma/
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 3 filings 0 executives 8 family 0
why_nownone on file
calls
Obviously, we'll build in launch expenses, but the synergies for meetings, for conferences, for other events, for the overlap and the targets, I don't see a significant expansion in the field because of the overlap in the targets. We will adequately prepare for a strong launch with 102. But yes, there are significant synergies that we can take from gel mito.
Aug 10, 2023 / receipt, needs a key / Jeff Bova, Chief Commercial Officer | earnings call 2023-08-10 | transcript 633bdc51-1265-4326-8383-d9d5c97d0ca7 | chars 20488-20848 | segment 21
To underscore this point even further, field-related travel and entertainment expenses were up 15-fold from January to February, and we saw another four-fold jump from February to March. Our ability to have meetings in offices and conduct live speaker programs played an important role in our strong finish to the first quarter and the great start we had to Q2.
May 13, 2021 / receipt, needs a key / Jeff, Chief Commercial Officer | earnings call 2021-05-13 | transcript c5b8d162-0d1d-4baf-b5a8-5817625f7fc6 | chars 11097-11458 | segment 11
And as it relates to spending quarter of a quarter for the year, I think, you know, you saw Q1 was a little bit lower largely because of COVID, some T&E commercial spends.
May 13, 2021 / receipt, needs a key / Molly, other | earnings call 2021-05-13 | transcript c5b8d162-0d1d-4baf-b5a8-5817625f7fc6 | chars 37492-37663 | segment 38
filingsnone on file
executives
| Christopher Degnan | Chief Financial Officer | - | receipt |
| Don Kim | CFO | - | receipt |
| Dong (Don) Kim | Chief Financial Officer | - | receipt |
| Jeff Bova | Chief Commercial Officer | - | receipt |
| Liz Barrett | CEO | - | receipt |
| Mark Schoenberg | Chief Medical Officer | - | receipt |
| Mollie Henderson | Chief Financial Officer | - | receipt |
| Molly Henderson | Chief Financial Officer | - | receipt |
familynone on file
upcoming
| 2026-11-05 | earnings call | scheduled | ir |
changes
| 2024-10-09 | Chief Financial Officer, appointed | sec_8k |
| 2022-03-21 | Chief Financial Officer, appointed | sec_8k |
| 2020-09-09 | Chief Financial Officer, appointed | sec_8k |
mcp_package_hint
slug urogen-pharma-ltd
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$